Discontinued Operations - Narratives (Details) - USD ($)		12 Months Ended
	Dec. 27, 2023	Dec. 31, 2023	Dec. 11, 2023	Dec. 31, 2022
Discontinued Operations
Estimated fair value of 3% ANTHIM earnout		$ 1,720,000
Gain from disposal of discontinued operations		1,467,451
Assets of discontinued operations				$ 7,928,136
Liabilities of discontinued operations				$ 5,290,500
Discontinued Operations, Disposed of by Sale | Elusys Therapeutics
Discontinued Operations
Purchase price	$ 2,488,000
Cash received	500,000		$ 500,000
Contingent consideration receivable	300,000
Estimated fair value of 3% ANTHIM earnout	1,720,000
Gain from disposal of discontinued operations	$ 1,467,451
Assets of discontinued operations		0
Liabilities of discontinued operations		$ 0